Associate Professor, Medicine-Brigham and Women's Hospital, Harvard Medical School
Hematology
Dr. Corey S. Cutler, MD
|
|
Give Review
Corey Cutler practices Hematology. He over the years received 1 awards: "Super Doctor". Corey Cutler is a published physician. He has 72 papers published. The most current publication "Selected Reviews from the 2016 BMT Tandem Meetings."
Publications
- Selected Reviews from the 2016 BMT Tandem Meetings.
- Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Wor...
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
- Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic Cancers after allogeneic hematopoietic stem cell transplan...
- Mammalian Target of Rapamycin Inhibitor-Associated Stomatitis in Hematopoietic Stem Cell Transplantation Patients Receiving Sirolimus Prophylaxis for Graft-versus-Host...
- BK polyomavirus reactivation after reduced-intensity double umbilical cord blood Cell transplantation.
- Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloi...
- Allogeneic hematopoietic Cell transplantation for mycosis fungoides and Sezary syndrome.
- Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-Cell transplantation.
- Outcomes and management strategies for Graft failure after umbilical cord blood transplantation.
- Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic Cell transplantation.
- Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival.
- Increased T follicular helper cells and germinal center B cells are required for Chronic GVHD (cGVHD) and bronchiolitis obliterans.
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines of the American Society for Blood and Marrow...
- Impact of Age on Quality of Life, Functional Status and Survival in Patients with Chronic Graft-versus-Host Disease.
- Assessment of joint and fascia manifestations in Chronic graft-versus-host disease.
- Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in Chronic gr...
- White blood Cell recovery after allogeneic hematopoietic Cell transplantation predicts clinical outcome.
- Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease.
- Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem Cell transplantation.
- Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Prostaglandin-modulated umbilical cord blood hematopoietic stem Cell transplantation.
- Role of reduced-intensity conditioning allogeneic hematopoietic stem-Cell transplantation in older patients with de novo myelodysplastic syndromes: an international co...
- Impact of donor source on hematopoietic Cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).
- Analysis of Gastrointestinal and Hepatic Chronic Grant-versus-Host Disease Manifestations on Major Outcomes: A Chronic Grant-versus-Host Disease Consortium Study.
- Comorbidity burden in patients with Chronic GVHD.
- Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with Chronic graft-versus-host disease.
- Hand Grip Strength and 2-Minute Walk Test in Chronic Graft-versus-Host Disease Assessment: Analysis from the Chronic GVHD Consortium.
- Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic Leukemia: prognostic model to predict outcome.
- Measurement of oral Chronic GVHD: results from the Chronic GVHD Consortium.
- KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.
- Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with Acute leukemia.
- Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated Acute limbic encephalitis: a cohort analysis.
- Biomarkers for Acute GVHD: can we predict the unpredictable?
- Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive Disease.
- Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation.
- Transplantation for MDS in the Elderly: More Evidence, or More Bias?
- Expression of CD30 in patients with Acute graft-vs.-host disease.
- Does iron overload really matter in stem Cell transplantation?
- Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients.
- Risk factors for Acute GVHD and survival after hematopoietic cell transplantation.
- The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.
- Cord colitis syndrome in cord-blood stem-Cell transplantation.
- Risk factors associated with increased non-relapse mortality and with poor overall survival in children with Chronic graft-versus-host disease.
- Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood Grafts.
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem Cell transplantation recipients.
- Recovery of B-cell homeostasis after rituximab in Chronic graft-versus-host disease.
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and Acute myeloid leukemia.
- High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
- Altered B-cell homeostasis and excess BAFF in human Chronic graft-versus-host disease.
- Improved survival in Lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with redu...
- Sirolimus is associated with veno-occlusive Disease of the liver after myeloablative allogeneic stem cell transplantation.
- Severe Acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
- Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin Lymphoma: importance of histology for outcome.
- A prognostic score for patients with Acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
- Case records of the Massachusetts General Hospital. Case 38-2007. A 44-year-old woman with generalized, painful, ulcerated Skin lesions.
- High levels of B-cell activating factor in patients with active Chronic graft-versus-host disease.
- Sirolimus-based Graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort ...
- Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem Cell transplantation.
- High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A Systematic review and meta-analysis of randomized ...
- Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem Cell transplantation.
- A decision analysis of allogeneic bone marrow transplantation for the Myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with...
- Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters Immune reconstitution after UCBT.
Schools
McGill University Faculty Of Medicine
McGill University
Dana Farber Canc Center Ptnrs Canc Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Central Nervous System Lymphoma
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Brigham and Women's Hospital -
McGill University Faculty of Medicine
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Martha Wadleigh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugene H. Choi, MD |
|
|
Dr. Stefanie Sarantopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Griffin, MD |
|
|
Dr. Robert J. Mayer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. George D. Demetri, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary-Ellen Taplin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Kala Seetharaman, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent T. Ho, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Irene M. Ghobrial, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Edwin P. Alyea III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary S. Spigelman, MD
This Doctor is OpenDoctor Recommended.
|